Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
388
datasets available to search
ShareScore release 0.9.0
Dataset results
388 results for “immune checkpoint inhibitors”
Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma
ClinicalTrials.gov study NCT05308901. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Role of SNP rs2910164 in Patients Treated With Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT04038996. IPD Sharing: Not stated. Countries: 0. Publications: 3.
A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT03311334. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT07357636. IPD Sharing: YES. Countries: 1. Publications: 0.
Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease
ClinicalTrials.gov study NCT03709771. IPD Sharing: YES. Countries: 1. Publications: 0.
PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study
ClinicalTrials.gov study NCT04115410. IPD Sharing: Not stated. Countries: 0. Publications: 9.
Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT04696055. IPD Sharing: NO. Countries: 8. Publications: 0.
Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis
ClinicalTrials.gov study NCT06785974. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive
ClinicalTrials.gov study NCT05879822. IPD Sharing: YES. Countries: 9. Publications: 0.
Identification of an Immune Single Cell Transcriptomic Profile of Responder and Non-responder Hepatocellular Carcinoma Patients Treated With Immune-checkpoint Inhibitors
ClinicalTrials.gov study NCT07273708. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT04925947. IPD Sharing: NO. Countries: 1. Publications: 0.
Preoperative Immune Checkpoint Inhibitor for Patients With Primary Untreated or Recurrent/Metastatic SCCHN
ClinicalTrials.gov study NCT03878979. IPD Sharing: NO. Countries: 1. Publications: 0.
Immune Checkpoint Inhibitor and MR-guided SBRT for Limited Progressive Metastatic Carcinoma.
ClinicalTrials.gov study NCT04376502. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Data from: Immune checkpoint inhibitor–related myositis and myocarditis in patients with cancer
Open the record for dataset details and reuse information.
Supplementary material of article entitled: Neurological adverse events of immune checkpoint inhibitors: A systematic review of 428 cases
Open the record for dataset details and reuse information.
TNF signature in advanced melanoma patients treated with immune checkpoint inhibitors: results from the MELANFα clinical study
GEO Series GSE289084. Homo sapiens. 32 samples. Type: Expression profiling by high throughput sequencing; Other.
Ceramide metabolism alterations contribute to Tumor Necrosis Factor-induced melanoma dedifferentiation and predict resistance to immune checkpoint inhibitors in advanced melanoma patients [WM35]
GEO Series GSE270741. Homo sapiens. 26 samples. Type: Expression profiling by high throughput sequencing.
Clonally expanded effector CD4+ cytotoxic T lymphocytes are associated with severe neurological adverse events after immune checkpoint inhibitor therapy
GEO Series GSE278119. Homo sapiens. 44 samples. Type: Expression profiling by high throughput sequencing; Other.
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitor therapy
GEO Series GSE173303. Homo sapiens. 16 samples. Type: Expression profiling by high throughput sequencing.
Inflammatory Conditions Promote Resistance to Immune Checkpoint Inhibitors in High Microsatellite Instability Colorectal Cancer
GEO Series GSE179784. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.